Medtronic (MDT) receives FDA expanded approval for cardiac cryoablation catheters for pediatric treatment of a common heart rhythm condition
Go back to Medtronic (MDT) receives FDA expanded approval for cardiac cryoablation catheters for pediatric treatment of a common heart rhythm condition| Medtronic Inc. (NYSE: MDT) | Delayed: 80.33 +80.32 (803,200.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.01 | 52 Week High | $89.27 | |||
| Open | $80.33 | 52 Week Low | $71.03 | |||
| Day High | $80.33 | P/E | 22.82 | |||
| Day Low | $80.33 | EPS | $3.52 | |||
| Volume | 2,585 | |||||
